Platinum Investment Management’s Arcus Biosciences RCUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.25M	Hold	153,783	–	–	0.08%	70
2025 Q1	$1.21M	Hold	153,783	–	–	0.07%	68
2024 Q4	$2.29M	Hold	153,783	–	–	0.13%	58
2024 Q3	$2.35M	Hold	153,783	–	–	0.11%	63
2024 Q2	$2.34M	Sell	153,783 -50,615	-25%	-$771K	0.09%	61
2024 Q1	$3.86M	Hold	204,398	–	–	0.16%	49
2023 Q4	$3.9M	Hold	204,398	–	–	0.16%	59
2023 Q3	$3.67M	Sell	204,398 -28,214	-12%	-$506K	0.14%	57
2023 Q2	$4.72M	Hold	232,612	–	–	0.16%	57
2023 Q1	$4.24M	Buy	232,612 +77,761	+50%	+$1.42M	0.15%	61
2022 Q4	$3.2M	Buy	154,851 +93,071	+151%	+$1.92M	0.12%	65
2022 Q3	$1.62M	Hold	61,780	–	–	0.07%	84
2022 Q2	$1.57M	Hold	61,780	–	–	0.06%	91
2022 Q1	$1.95M	Hold	61,780	–	–	0.06%	85
2021 Q4	$2.5M	Hold	61,780	–	–	0.07%	88
2021 Q3	$2.15M	Sell	61,780 -13,510	-18%	-$471K	0.06%	98
2021 Q2	$2.07M	Hold	75,290	–	–	0.05%	92
2021 Q1	$2.11M	Sell	75,290 -11,768	-14%	-$330K	0.05%	86
2020 Q4	$2.26M	Hold	87,058	–	–	0.05%	88
2020 Q3	$1.49M	Hold	87,058	–	–	0.04%	91
2020 Q2	$2.15M	Sell	87,058 -16,682	-16%	-$413K	0.05%	82
2020 Q1	$1.44M	Hold	103,740	–	–	0.04%	84
2019 Q4	$1.05M	Sell	103,740 -33,153	-24%	-$335K	0.02%	85
2019 Q3	$1.25M	Sell	136,893 -9,300	-6%	-$84.6K	0.03%	78
2019 Q2	$1.16M	Hold	146,193	–	–	0.03%	81
2019 Q1	$1.83M	Hold	146,193	–	–	0.04%	69
2018 Q4	$1.57M	Buy	146,193 +50,352	+53%	+$542K	0.05%	59
2018 Q3	$1.34M	Buy	95,841 +43,000	+81%	+$599K	0.04%	65
2018 Q2	$647K	Buy	52,841 +42,841	+428%	+$525K	0.02%	81
2018 Q1	$154K	Buy	+10,000	New	+$154K	﹤0.01%	85